SKT:NYSETanger Inc. Analysis
Data as of 2026-09-01 - not real-time
$37.71
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
Tanger Inc. is priced at $37.71, and its moving averages give no clean directional read — the structure is neutral. Across the trailing 30 sessions it lost 9.4%. With RSI at 34.3 the momentum picture is approaching oversold, alongside a bearish MACD signal. Recent trading has carved out support near $37.38 and resistance around $41.32.
Valuation screens as fair: a P/E of 34.6 sits in line with the sector average of 32.0. The average analyst target implies 9.7% above today's level. Revenue is growing at 11.5% on a 20.2% profit margin. The 3.31% dividend yield looks stretched against payout coverage.
On a 1-10 scale the risk profile lands at 3 — low. With 30-day volatility of 16.1%, a beta of 0.32 and a maximum drawdown of 10.6%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 3/10.
Valuation screens as fair: a P/E of 34.6 sits in line with the sector average of 32.0. The average analyst target implies 9.7% above today's level. Revenue is growing at 11.5% on a 20.2% profit margin. The 3.31% dividend yield looks stretched against payout coverage.
On a 1-10 scale the risk profile lands at 3 — low. With 30-day volatility of 16.1%, a beta of 0.32 and a maximum drawdown of 10.6%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 3/10.
Top Market Events
Core FFO up 10.3% to $0.64 per share, with full-year guidance raised to $2.45-$2.52, driven by solid leasing momentum...Tanger earnings and guidance update Tanger SKT recently reported its second quarter 2026 results, with revenue, net...The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading above the 200-day average of 36.21
- MACD momentum is negative
- 30-day price change of -9.4%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 34.6 versus sector average of 32.0
- Dividend yield of 3.31% looks stretched against payout coverage
- Trading above the 200-day average of 36.21
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 34.6 versus sector average of 32.0
- Dividend yield of 3.31% looks stretched against payout coverage
- Analyst targets imply +9.7% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth11.50%
Profit Margin20.23%
P/E Ratio34.6
ROE19.40%
ROA4.71%
Debt/Equity278.31
P/B Ratio6.4
Op. Cash Flow$301.7M
Free Cash Flow$227.8M
Industry P/E32.0
Technical Analysis
TrendNeutral
RSI34.3
Support$37.38
Resistance$41.32
MA 20$38.64
MA 50$39.79
MA 200$36.21
MACDBearish
VolumeDecreasing
Fear & Greed Index94.34
Valuation
Fair Value$24.46
Target Price$41.36
Upside/Downside9.69%
GradeFair
TypeBlend
Dividend Yield3.31%
Risk Assessment
Beta0.32
Volatility16.07%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.